Vita Coco Thrives: Net Sales Up 24% to $482M, Net Income Jumps 25%
Ticker: COCO · Form: 10-Q · Filed: 2025-10-29T00:00:00.000Z
Sentiment: bullish
Topics: Beverage Industry, Coconut Water, Financial Performance, Growth Stock, Consumer Staples, Earnings Report, Public Benefit Corporation
Related Tickers: COCO, KO, PEP, MNST
TL;DR
**COCO is crushing it with double-digit sales and profit growth, making it a solid bet in the beverage sector.**
AI Summary
The Vita Coco Company, Inc. (COCO) reported robust financial performance for the nine months ended September 30, 2025, with net sales increasing to $481.993 million, a significant rise from $388.720 million in the prior year. Net income also saw a substantial jump to $65.793 million, up from $52.582 million in the same period of 2024. Gross profit improved to $178.018 million from $157.476 million, despite a rise in cost of goods sold to $303.975 million. The company experienced a notable unrealized gain on derivative instruments of $6.275 million, a positive reversal from a $5.896 million loss in 2024. Cash and cash equivalents increased to $203.705 million from $164.669 million at December 31, 2024, reflecting strong cash flow from operating activities of $51.069 million. Accounts receivable grew to $103.387 million, and inventory remained stable at $84.418 million. Strategic outlook includes continued focus on its Vita Coco brand and expansion into other beverage categories like Ever & Ever water and PWR LIFT protein drinks, while managing risks associated with customer concentration and macroeconomic instability.
Why It Matters
This strong performance by Vita Coco demonstrates resilience and growth in a competitive beverage market, signaling positive momentum for investors. The significant increase in net sales and net income suggests effective brand management and market penetration, potentially leading to increased shareholder value. For employees, sustained growth could mean job security and opportunities. Customers benefit from continued product availability and potential innovation. The broader market sees a strong player in the healthy beverage segment, potentially influencing competitors to innovate and expand their offerings.
Risk Assessment
Risk Level: medium — The company faces a medium risk level primarily due to significant customer concentration, with two customers collectively representing 45% of total net sales for the nine months ended September 30, 2025, and 36% of total accounts receivable. This reliance on a few major customers could materially impact financial condition if one were lost or reduced purchases. Additionally, macroeconomic instability, including geopolitical conflicts and high interest rates, poses a risk to estimates and future performance.
Analyst Insight
Investors should consider Vita Coco's strong financial performance and market position, but remain aware of the customer concentration risk. Monitor future filings for diversification efforts and any changes in relationships with major customers. This could be a good long-term hold for growth-oriented investors.
Financial Highlights
- debt To Equity
- 0.42
- revenue
- $481.993M
- operating Margin
- 15.01%
- total Assets
- $461.294M
- total Debt
- $137.561M
- net Income
- $65.793M
- eps
- $0.42
- gross Margin
- 36.93%
- cash Position
- $203.705M
- revenue Growth
- +24%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Vita Coco | $481.993M | +24% |
Key Numbers
- $481.993M — Net sales (Increased from $388.720M in 2024, a 24% increase)
- $65.793M — Net income (Increased from $52.582M in 2024, a 25% increase)
- $178.018M — Gross profit (Increased from $157.476M in 2024)
- $203.705M — Cash and cash equivalents (Increased from $164.669M at December 31, 2024)
- $51.069M — Net cash provided by operating activities (Increased from $35.977M in 2024)
- 45% — Customer concentration (Percentage of total net sales from two major customers for nine months ended September 30, 2025)
- $6.275M — Unrealized gain on derivative instruments (Positive reversal from a $5.896M loss in 2024)
- $103.387M — Accounts receivable, net (Increased from $63.450M at December 31, 2024)
- $84.418M — Inventory (Stable compared to $83.600M at December 31, 2024)
- $0.42 — Basic net income per common share (Increased from $0.34 for the three months ended September 30, 2024)
Key Players & Entities
- The Vita Coco Company, Inc. (company) — Registrant and primary business entity
- Vita Coco (company) — Primary brand name for coconut water products
- Ever & Ever (company) — Brand name for water products
- PWR LIFT (company) — Brand name for protein infused fitness drinks
- Delaware General Corporation Law (regulator) — Governs the company's status as a public benefit corporation
- Financial Accounting Standards Board (regulator) — Issued Accounting Standards Update in November 2023
- Federal Deposit Insurance Corporation (regulator) — Guarantees cash deposits up to $250,000
- All Market Europe, Ltd. (company) — Wholly-owned subsidiary in the United Kingdom
- Coco Ventures Limited (company) — 60% joint venture interest in China
- The Nasdaq Stock Market LLC (regulator) — Exchange where Common Stock is registered
FAQ
What were Vita Coco's net sales for the nine months ended September 30, 2025?
Vita Coco's net sales for the nine months ended September 30, 2025, were $481.993 million, a significant increase from $388.720 million reported for the same period in 2024.
How did Vita Coco's net income change year-over-year for the nine months ended September 30, 2025?
Net income for Vita Coco increased to $65.793 million for the nine months ended September 30, 2025, up from $52.582 million in the prior year, representing a 25% increase.
What is Vita Coco's cash position as of September 30, 2025?
As of September 30, 2025, Vita Coco reported cash and cash equivalents of $203.705 million, an increase from $164.669 million at December 31, 2024.
What is the primary risk factor identified in Vita Coco's 10-Q filing?
A primary risk factor for Vita Coco is customer concentration, with two major customers accounting for 45% of total net sales and 36% of total accounts receivable for the nine months ended September 30, 2025.
How much cash did Vita Coco generate from operating activities for the nine months ended September 30, 2025?
Vita Coco generated $51.069 million in net cash from operating activities for the nine months ended September 30, 2025, compared to $35.977 million in the same period of 2024.
What was the unrealized gain on derivative instruments for Vita Coco in the nine months ended September 30, 2025?
Vita Coco reported an unrealized gain on derivative instruments of $6.275 million for the nine months ended September 30, 2025, a significant improvement from a $5.896 million loss in the prior year.
What is Vita Coco's status as a public benefit corporation?
Vita Coco is a public benefit corporation under Section 362 of the Delaware General Corporation Law, requiring its Board of Directors to balance stockholder interests, stakeholder interests, and specific public benefits.
How many shares of common stock were outstanding for Vita Coco as of October 27, 2025?
As of October 27, 2025, there were 56,948,258 shares of Vita Coco's common stock, par value $0.01 per share, outstanding.
What are some of Vita Coco's other product brands besides Vita Coco coconut water?
Beyond Vita Coco coconut water, the company also markets water under the brand name Ever & Ever and protein-infused fitness drinks under the brand name PWR LIFT.
Did Vita Coco experience any significant changes in accounting policies during the nine months ended September 30, 2025?
No, during the nine months ended September 30, 2025, there were no significant changes to Vita Coco's significant accounting policies as described in the company's audited consolidated financial statements for the year ended December 31, 2024.
Risk Factors
- Customer Concentration [high — financial]: The company's reliance on two major customers for 45% of its total net sales presents a significant risk. A loss of or reduction in business from these key customers could materially impact revenue and profitability.
- Macroeconomic Instability [medium — market]: Global economic uncertainties, including inflation and potential recessions, could affect consumer spending on non-essential beverages and increase operating costs.
- Supply Chain Disruptions [medium — operational]: The company's operations are dependent on global supply chains for raw materials and finished goods. Disruptions due to geopolitical events, natural disasters, or logistical challenges could impact product availability and costs.
- Changing Consumer Preferences and Health Trends [medium — regulatory]: Shifts in consumer preferences towards healthier or alternative beverages, or changes in regulations related to food and beverage labeling or ingredients, could negatively affect demand for Vita Coco products.
- Foreign Currency Exchange Rate Fluctuations [low — financial]: As a global company, Vita Coco is exposed to fluctuations in foreign currency exchange rates, which can impact reported revenues, costs, and profits when translated into U.S. dollars.
Industry Context
The beverage industry, particularly the functional and healthy beverage segment, is highly competitive and dynamic. Vita Coco operates within this space, facing competition from established global brands and emerging niche players. Key trends include growing consumer demand for plant-based and natural ingredients, functional benefits (like hydration and energy), and sustainable sourcing. The market is also influenced by evolving consumer preferences and regulatory landscapes.
Regulatory Implications
Vita Coco must navigate various regulations concerning food and beverage labeling, ingredient disclosures, and marketing claims. Changes in these regulations, particularly regarding health benefits or nutritional content, could require product reformulation or marketing adjustments. Compliance with international trade and customs regulations is also crucial for its global operations.
What Investors Should Do
- [object Object]
- [object Object]
- [object Object]
- [object Object]
Key Dates
- 2025-09-30: Nine months ended September 30, 2025 — Reported significant growth in net sales to $481.993M and net income to $65.793M, demonstrating strong operational performance.
- 2024-12-31: As of December 31, 2024 — Company held $164.669M in cash and cash equivalents, providing a solid liquidity base.
- 2025-09-30: Accounts receivable, net — Increased to $103.387M, indicating higher sales volume but also a potential increase in working capital needs.
- 2025-09-30: Net cash provided by operating activities — Reached $51.069M, a substantial increase from the prior year, highlighting strong cash generation from core business operations.
Glossary
- Unrealized gain/(loss) on derivative instruments
- The change in value of financial contracts (like futures or options) that have not yet been settled. A gain increases income, while a loss decreases it. (A positive reversal from a loss of $5.896M in 2024 to a gain of $6.275M in 2025 significantly boosted net income.)
- Right-of-use assets, net
- Represents the value of a company's right to use an asset (like a building or equipment) for a specified period under a lease agreement. (The significant increase from $385K to $11.896M suggests new lease agreements, potentially for expanded operations or facilities.)
- Accumulated other comprehensive income (loss)
- A component of equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and other items not recognized in net income. (The shift from a net loss of $860K to a net gain of $549K indicates favorable movements in these non-operating items.)
- Treasury stock
- Shares of a company's own stock that it has repurchased from the open market. It reduces the number of outstanding shares. (The increase in treasury stock from $71.731M to $81.935M suggests the company continued its share repurchase program.)
- Supplier advances, current
- Payments made to suppliers for goods or services that have not yet been received or rendered. (A decrease from $954K to $767K might indicate a shift in payment terms or reduced pre-payments.)
Year-Over-Year Comparison
Vita Coco Company, Inc. has demonstrated strong year-over-year growth, with net sales increasing by 24% to $481.993 million for the nine months ended September 30, 2025. Net income also saw a substantial 25% rise to $65.793 million. Gross profit improved, and the company significantly boosted its cash position to $203.705 million, driven by robust operating cash flow of $51.069 million. A notable positive development is the reversal of unrealized losses on derivative instruments to a gain, contributing to the improved profitability. However, accounts receivable have grown considerably, indicating a potential increase in working capital requirements.
Filing Stats: 4,645 words · 19 min read · ~15 pages · Grade level 16.6 · Accepted 2025-10-29 08:56:37
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 Per Share COCO The Nasdaq Stock Market
- $250 — it Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess o
Filing Documents
- coco-20250930.htm (10-Q) — 1400KB
- coco20250930-exx311martinr.htm (EX-31.1) — 10KB
- coco20250930-exx312coreyba.htm (EX-31.2) — 10KB
- coco20250930-10qexx321ceo.htm (EX-32.1) — 4KB
- coco20250930-10qexx322cfo.htm (EX-32.2) — 4KB
- 0001628280-25-046935.txt ( ) — 6705KB
- coco-20250930.xsd (EX-101.SCH) — 42KB
- coco-20250930_cal.xml (EX-101.CAL) — 49KB
- coco-20250930_def.xml (EX-101.DEF) — 194KB
- coco-20250930_lab.xml (EX-101.LAB) — 536KB
- coco-20250930_pre.xml (EX-101.PRE) — 394KB
- coco-20250930_htm.xml (XML) — 933KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Operations & Other Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2025 and 2024 7 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 9 Notes to Condensed Consolidated Financial Statements 10 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 34 Item 4.
Controls and Procedures
Controls and Procedures 35
- OTHER INFORMATION
PART II - OTHER INFORMATION Item 1.
Legal Proceedings
Legal Proceedings 37 Item 1A.
Risk Factors
Risk Factors 37 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 37 Item 3. Defaults Upon Senior Securities 37 Item 4. Mine Safety Disclosures 37 Item 5. Other Information 37 Item 6. Exhibits 39
Signatures
Signatures 41 2 Table of Contents
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "forecasts," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements regarding our future results of operations and financial position, industry and business trends, equity compensation, business strategy, projected costs, plans, prospects, expectations, market growth, new products, supply chain predictions, and our objectives for future operations. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed in Part I, Item 1A. "Risk Factors" in our Ann
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements. THE VITA COCO COMPANY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Amounts in thousands, except share data) September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 203,705 $ 164,669 Accounts receivable, net of allowance of $ 3,469 at September 30, 2025, and $ 2,255 at December 31, 2024 103,387 63,450 Inventory 84,418 83,600 Supplier advances, current 767 954 Derivative assets 2,177 1,382 Prepaid expenses and other current assets 28,876 27,236 Total current assets 423,330 341,291 Property and equipment, net 7,207 2,351 Goodwill 7,791 7,791 Supplier advances, long-term 2,392 2,254 Deferred tax assets, net 6,098 6,100 Right-of-use assets, net 11,896 385 Other assets 2,580 2,209 Total assets $ 461,294 $ 362,381 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 22,262 $ 30,758 Accrued expenses and other current liabilities 99,775 65,603 Notes payable, current 5 10 Derivative liabilities 1,415 6,895 Total current liabilities 123,457 103,266 Notes payable, long-term — 3 Operating lease liability, long-term 14,006 — Other long-term liabilities 98 295 Total liabilities 137,561 103,564 Commitments and contingencies (See Note 7) Stockholders' equity: Common stock, $ 0.01 par value; 500,000,000 shares authorized; 64,027,120 and 63,702,387 shares issued at September 30, 2025 and December 31, 2024, respectively; 56,948,258 and 56,961,941 shares outstanding at September 30, 2025 and December 31, 2024, respectively 640 637 Additional paid-in capital 181,992 174,077 Retained earnings 222,487 156,694 Accumulated other comprehensive income (loss) 549 ( 860 ) Treasury stock, 7,078,862 shares at cost as of September 30, 2025, and 6,740,446 shares at cost as of December 31, 2024. ( 81,935 ) ( 71,731 ) Total stockholders' equity 323,733 258,817 Total liabilities and stockholders' equity $ 461,294 $ 362,381 See accom